Lsv Asset Management Astrazeneca PLC Transaction History

Lsv Asset Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$61.03 - $69.57 $891,038 - $1.02 Million	-14,600 Reduced 19.41%	60,600 $4.11 Million
Q1 2023 May 02, 2023	SELL	$63.15 - $71.6 $1.14 Million - $1.29 Million	-18,000 Reduced 19.31%	75,200 $5.22 Million
Q2 2020 Aug 05, 2020	SELL	$43.1 - $55.31 $603,400 - $774,340	-14,000 Reduced 13.06%	93,200 $4.93 Million
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $3.1 Million - $3.64 Million	107,200	107,200 $3.63 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

Stay updated on Lsv Asset Management with notifications on news.